Steven Hersch
Harvard University
H-index: 79
North America-United States
Top articles of Steven Hersch
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Impact of Clinical Subgroup and Baseline Amyloid PET Centiloid Levels on Occurrence of ARIA in the Lecanemab Phase 3 Clarity AD Study in Early Alzheimer’s Disease (P1-9.007) | Marwan Sabbagh David Li Shobha Dhadda Steven Hersch Luigi Giorgi | 2024/4/14 | |
Isolated ARIA-H in patients treated with lecanemab in the phase 3 clarity AD study in early Alzheimer's disease | Journal of the Neurological Sciences | Marwan Sabbagh Jeffrey Cummings Chris Van Dyck Steven Hersch Michio Kanekiyo | 2023/12/1 |
Suicidality risk factors across the CARE-HD, 2CARE, and CREST-E clinical trials in Huntington disease | Neurology: Clinical Practice | Andrew McGarry Peggy Auinger Karl D Kieburtz Amy-Lee Bredlau Steven M Hersch | 2022/4 |
A natural history study to track brain and spinal cord changes in individuals with Friedreich’s ataxia: TRACK-FA study protocol | Plos one | Nellie Georgiou-Karistianis Louise A Corben Kathrin Reetz Isaac M Adanyeguh Manuela Corti | 2022/11/21 |
High-sensitivity immunoassay for the detection of frataxin in biofluids | 2022/9/29 | ||
The Vasopressin 1a receptor antagonist SRX246 reduces aggressive behavior in Huntington’s disease | Journal of Personalized Medicine | Hilda T Maibach Michael J Brownstein Steven M Hersch Karen E Anderson Debra E Itzkowitz | 2022/9/22 |
Compositions and methods for treating huntington's disease | 2022/9/1 | ||
Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial | Movement disorders | Douglas R Langbehn Elisabeth M Fine Andreas Meier Steven Hersch | 2022/5 |
Cannula system and use thereof | 2021/11/25 | ||
Systems and methods for producing gene therapy formulations | 2021/11/18 | ||
Volumetric MRI-based biomarkers in Huntington's disease: an evidentiary review | Kirsi M Kinnunen Adam J Schwarz Emily C Turner Dorian Pustina Emily C Gantman | 2021/9/21 | |
Impaired cerebrovascular reactivity in Huntington’s disease | Frontiers in Physiology | Suk Tak Chan Nathaniel D Mercaldo Kenneth K Kwong Steven M Hersch Herminia D Rosas | 2021/7/21 |
Association of dilated perivascular spaces and disease severity in patients with Huntington disease | Neurology | Suk Tak Chan Nathaniel D Mercaldo Bernard Ravina Steven M Hersch Herminia D Rosas | 2021/2/9 |
Clinical outcomes and selection criteria for prodromal Huntington's disease trials | Movement disorders | Douglas R Langbehn Steven Hersch | 2020/12 |
Safety and tolerability of srx246, a vasopressin 1a antagonist, in irritable Huntington’s disease patients—a randomized phase 2 clinical trial | Journal of clinical medicine | Michael J Brownstein Neal G Simon Jeffrey D Long Jon Yankey Hilda T Maibach | 2020/11/16 |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord | 2020/1/9 |
